Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Sonnenberg

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Science Translational Medicine|February 1, 2013
TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammationBrian S Kim, Mark C Siracusa, Steven A Saenz, et al.
Cell Reports|June 28, 2018
Anti-microbial Functions of Group 3 Innate Lymphoid Cells in Gut-Associated Lymphoid Tissues Are Regulated by G-Protein-Coupled Receptor 183Coco Chu, Saya Moriyama, Zhi Li, et al.
Nature Immunology|February 1, 2022
Group 3 innate lymphoid cells produce the growth factor HB-EGF to protect the intestine from TNF-mediated inflammationLei Zhou, Wenqing Zhou, Ann M Joseph, et al.
Nature|December 24, 2014
Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesityJonathan R Brestoff, Brian S Kim, Steven A Saenz, et al.
Nature|December 2, 2021
Antigen-presenting innate lymphoid cells orchestrate neuroinflammationJohn B Grigg, Arthi Shanmugavadivu, Tommy Regen, et al.
Nature Communications|January 10, 2015
CCR7-dependent trafficking of RORγ⁺ ILCs creates a unique microenvironment within mucosal draining lymph nodesEmma C Mackley, Stephanie Houston, Clare L Marriott, et al.
Nature Communications|March 30, 2016
Corrigendum: CCR7-dependent trafficking of RORγ(+) ILCs creates a unique microenvironment within mucosal draining lymph nodesEmma C Mackley, Stephanie Houston, Clare L Marriott, et al.
Immunity|June 19, 2012
Commensal bacteria calibrate the activation threshold of innate antiviral immunityMichael C Abt, Lisa C Osborne, Laurel A Monticelli, et al.
Nature Medicine|February 16, 2016
Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cellsDavid R Withers, Matthew R Hepworth, Xinxin Wang, et al.
Cell|August 18, 2021
Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancerJeremy Goc, Mengze Lv, Nicholas J Bessman, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Science Translational Medicine|February 1, 2013
TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammationBrian S Kim, Mark C Siracusa, Steven A Saenz, et al.
Cell Reports|June 28, 2018
Anti-microbial Functions of Group 3 Innate Lymphoid Cells in Gut-Associated Lymphoid Tissues Are Regulated by G-Protein-Coupled Receptor 183Coco Chu, Saya Moriyama, Zhi Li, et al.
Nature Immunology|February 1, 2022
Group 3 innate lymphoid cells produce the growth factor HB-EGF to protect the intestine from TNF-mediated inflammationLei Zhou, Wenqing Zhou, Ann M Joseph, et al.
Nature|December 24, 2014
Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesityJonathan R Brestoff, Brian S Kim, Steven A Saenz, et al.
Nature|December 2, 2021
Antigen-presenting innate lymphoid cells orchestrate neuroinflammationJohn B Grigg, Arthi Shanmugavadivu, Tommy Regen, et al.
Nature Communications|January 10, 2015
CCR7-dependent trafficking of RORγ⁺ ILCs creates a unique microenvironment within mucosal draining lymph nodesEmma C Mackley, Stephanie Houston, Clare L Marriott, et al.
Nature Communications|March 30, 2016
Corrigendum: CCR7-dependent trafficking of RORγ(+) ILCs creates a unique microenvironment within mucosal draining lymph nodesEmma C Mackley, Stephanie Houston, Clare L Marriott, et al.
Immunity|June 19, 2012
Commensal bacteria calibrate the activation threshold of innate antiviral immunityMichael C Abt, Lisa C Osborne, Laurel A Monticelli, et al.
Nature Medicine|February 16, 2016
Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cellsDavid R Withers, Matthew R Hepworth, Xinxin Wang, et al.
Cell|August 18, 2021
Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancerJeremy Goc, Mengze Lv, Nicholas J Bessman, et al.
Pageof 11